Standards for Reducing Risks Associated with ePMA for SACT

It is with great pleasure to announce that the BOPA Standards for Reducing Risks Associated with ePMA for SACT have been updated and can be found in the publication section of the members only section of the website.
These BOPA Standards for Reducing Risks Associated with Electronic Prescribing and Medicines Administration Systems (ePMA) for Systemic Anti-Cancer Therapies (SACT) outlines steps that can be considered to be best practice in reducing the risks of errors arising from the introduction and use of e-prescribing systems for SACT within organisations.
If you have any queries please direct them to

Latest News

By Emma Foreman on 13th September 2019

New Book Published by a BOPA Member!

One of our members has published a book!   ‘Can community pharmacists support patients who take oral anticancer medication?’ By Melanie Dalby is now available via Amazon here   The…

Read article
By Netty Cracknell on 12th September 2019

BOPA September Newsletter

The BOPA Sept Newsletter has gone out today. If you did not receive it and wish to receive future emails concerning BOPA including AGM information please log into the new…

Read article
By Rob Duncombe on 10th September 2019

Cruise the River Thames aboard the Dixie Queen

2019 Saturday, October 12, 2019 Meet at 19:30, 69 GBP per person  “Come see the sights of London from water, “Come see the sights of London from water, “Come…

Read article
By Nick Duncan and Simon Cheesman on 20th August 2019

BMT group study day

The fifth educational meeting of the UK BMT Pharmacists’ Group took place at the UCLH Education Centre, London on the afternoon of Friday 12th July 2019.  Over 30 pharmacists from…

Read article
Bubble circle image

BOPA/ISOPP Symposium 2019

Advancing Patient Care Through Global Collaboration

Thursday 10th – Sunday 13th October 2019
Novotel London West, London, UK

Everything you need to know